Nutrition Support for Head and Neck Squamous Cell Carcinoma Patients Treated with Chemoradiotherapy: How Often and How Long?

Table 1

	𝑛=53
Age	Median (range)	62 (45–77)
Gender	Male/female	49/4
Primary sites	OP/HP/L	22/24/7
T	1/2/3/4	2/18/12/21
N	0/1/2a/2b/2c/3	6/3/2/9/25/8
Stage	II/III/IV	4/3/46
Chemotherapy regimen	CDDP+5-FU+RT	30
	CDDP+RT	17
	Nedaplatin+5-FU+RT	3
	Carboplatin+RT	3
RT dose	Median (range)	70 (60–70)

Abbreviations; OP: Oropharynx, HP: Hypopharynx, and L: Larynx.